Pill Identifier App

BiPla

Dosage form: liquid
Ingredients: SUS SCROFA PLACENTA 16000mg in 30mL
Labeler: TMN K.K.
NDC Code: 52964-1001

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Facts

active ingredient: placenta extract

inactive ingredient: erythritol, trehalose, apple juice, DL-malic acid, straight chain oligo saccharide, iso malto oligo saccharide, collagen peptide, yucca form, caramel pigment, spice

for skin beauty

keep out of reach of the children

recommended daily intake:  drink 1 bottle per day

- persons with allergies should not drink this product
- the bottle is breakable. do not heat or freeze
- women up to 3 months pregnant or who wish to become pregnant should refrain from ingesting an excessive amount of this product

- ingredients may settle to the bottom, so shake well before drinking

BIPLA  
sus scrofa placenta liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52964-1001
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SUS SCROFA PLACENTA (SUS SCROFA PLACENTA) SUS SCROFA PLACENTA16000 mg  in 30 mL
Inactive Ingredients
Ingredient NameStrength
ERYTHRITOL 
TREHALOSE 
APPLE JUICE 
MALIC ACID 
CARAMEL 
Packaging
#Item CodePackage Description
1NDC:52964-1001-130 mL in 1 BOTTLE, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/02/2012
Labeler - TMN K.K. (711474452)
Registrant - TMN K.K. (711474452)
Establishment
NameAddressID/FEIOperations
TMN K.K.711474452manufacture(52964-1001)

Revised: 08/2012
 
TMN K.K.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)